{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T08:56:56Z","timestamp":1791622616860,"version":"4.3.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.phymed.2025.157500","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:49:03Z","timestamp":1761810543000},"page":"157500","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Guanxinning tablets plus aspirin versus aspirin monotherapy to reduce cardiovascular events after percutaneous coronary intervention: A cluster-randomized controlled trial (GAP trial)"],"prefix":"10.1016","volume":"149","author":[{"given":"Hao","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4233-950X","authenticated-orcid":false,"given":"Jingen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Kantas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2025.157500_bib0001","doi-asserted-by":"crossref","DOI":"10.5402\/2012\/246915","article-title":"Anemia in heart failure patients","volume":"2012","author":"Alexandrakis","year":"2012","journal-title":"ISRN Hematol."},{"issue":"19","key":"10.1016\/j.phymed.2025.157500_bib0002","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","article-title":"Long-term use of ticagrelor in patients with prior myocardial infarction","volume":"372","author":"Bonaca","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phymed.2025.157500_bib0003","doi-asserted-by":"crossref","first-page":"e5661","DOI":"10.1136\/bmj.e5661","article-title":"Consort 2010 statement: extension to cluster randomised trials","volume":"345","author":"Campbell","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.phymed.2025.157500_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114667","article-title":"Salvianolic acid b and ferulic acid synergistically promote angiogenesis in HUVECS and zebrafish via regulating VEGF signaling","volume":"283","author":"Chen","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phymed.2025.157500_bib0005","doi-asserted-by":"crossref","first-page":"8047","DOI":"10.2147\/JIR.S490896","article-title":"Guanxinning for residual inflammation of stable coronary artery disease: a pilot randomized controlled trial","volume":"17","author":"Chen","year":"2024","journal-title":"J. Inflamm. Res."},{"issue":"5","key":"10.1016\/j.phymed.2025.157500_bib0006","doi-asserted-by":"crossref","first-page":"e701","DOI":"10.1016\/S2214-109X(20)30541-6","article-title":"The role and challenges of cluster randomised trials for global health","volume":"9","author":"Dron","year":"2021","journal-title":"Lancet. Glob. Health N. Hav."},{"issue":"8","key":"10.1016\/j.phymed.2025.157500_bib0007","doi-asserted-by":"crossref","first-page":"281","DOI":"10.31083\/j.rcm2508281","article-title":"Current antithrombotic treatments for cardiovascular diseases: a comprehensive review","volume":"25","author":"Galanti","year":"2024","journal-title":"Rev. Cardiovasc. Med."},{"issue":"6","key":"10.1016\/j.phymed.2025.157500_bib0008","doi-asserted-by":"crossref","first-page":"717","DOI":"10.4244\/EIJ-D-17-00468","article-title":"State of the art: duration of dual antiplatelet therapy after percutaneous coronary intervention and coronary stent implantation \u2013 past, present and future perspectives","volume":"13","author":"Gargiulo","year":"2017","journal-title":"EuroIntervention"},{"issue":"3","key":"10.1016\/j.phymed.2025.157500_bib0009","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jclinepi.2004.08.012","article-title":"Intraclass correlation coefficient and outcome prevalence are associated in clustered binary data","volume":"58","author":"Gulliford","year":"2005","journal-title":"J. Clin. Epidemiol."},{"issue":"13","key":"10.1016\/j.phymed.2025.157500_bib0010","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1093\/eurheartj\/ehab741","article-title":"Chinese expert consensus statement on dual antiplatelet therapy in patients with coronary artery disease","volume":"43","author":"Han","year":"2022","journal-title":"Eur. Heart. J."},{"issue":"10","key":"10.1016\/j.phymed.2025.157500_bib0011","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41569-024-01046-6","article-title":"Global epidemiology of heart failure","volume":"21","author":"Khan","year":"2024","journal-title":"Nat. Rev. Cardiol."},{"issue":"15","key":"10.1016\/j.phymed.2025.157500_bib0012","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1161\/CIRCULATIONAHA.120.046308","article-title":"Dual antiplatelet therapy after percutaneous coronary intervention and drug-eluting stents: a systematic review and network meta-analysis","volume":"142","author":"Khan","year":"2020","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.phymed.2025.157500_bib0013","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.phymed.2025.157500_bib0014","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13063-017-2373-x","article-title":"Guanxinning tablet for patients who switch from dual antiplatelet therapy to aspirin alone after percutaneous coronary intervention: study protocol for a cluster randomized controlled trial","volume":"19","author":"Li","year":"2018","journal-title":"Trials"},{"key":"10.1016\/j.phymed.2025.157500_bib0015","article-title":"Synergistic effects of cryptotanshinone and senkyunolide I in Guanxinning tablet against endogenous thrombus formation in zebrafish","volume":"11","author":"Li","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2025.157500_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1419169","article-title":"Traditional Chinese medicine for cardiovascular disease: efficacy and safety","volume":"11","author":"Lin","year":"2024","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.phymed.2025.157500_bib0017","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.754527","article-title":"Vasodilatory effect of Guanxinning tablet on rabbit thoracic aorta is modulated by both endothelium-dependent and -independent mechanism","volume":"12","author":"Ling","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"23","key":"10.1016\/j.phymed.2025.157500_bib0018","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","article-title":"Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents","volume":"371","author":"Mauri","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"39","key":"10.1016\/j.phymed.2025.157500_bib0019","article-title":"Molecular targets and mechanisms of guanxinning tablet in treating atherosclerosis: network pharmacology and molecular docking analysis","volume":"102","author":"Niu","year":"2023","journal-title":"Med. (Baltimore)Med."},{"issue":"1","key":"10.1016\/j.phymed.2025.157500_bib0020","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/eurheartj\/ehn480","article-title":"Long-term effectiveness of early administration of glycoprotein IIb\/IIIa agents to real-world patients undergoing primary percutaneous interventions: results of a registry study in an ST-elevation myocardial infarction network","volume":"30","author":"Ortolani","year":"2009","journal-title":"Eur. Heart J."},{"issue":"16","key":"10.1016\/j.phymed.2025.157500_bib0021","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/j.jacc.2017.02.029","article-title":"Bleeding-related deaths in relation to the duration of dual-antiplatelet therapy after coronary stenting","volume":"69","author":"Palmerini","year":"2017","journal-title":"J Am. Coll. Cardiol."},{"issue":"9985","key":"10.1016\/j.phymed.2025.157500_bib0022","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1016\/S0140-6736(15)60263-X","article-title":"Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise, bayesian network meta-analysis of randomised trials","volume":"385","author":"Palmerini","year":"2015","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.phymed.2025.157500_bib0023","first-page":"e771","article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"151","author":"Rao","year":"2025","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.phymed.2025.157500_bib0024","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1161\/CIR.0000000000001168","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College Of Cardiology joint committee on clinical practice guidelines","volume":"148","author":"Virani","year":"2023","journal-title":"Circulation"},{"issue":"36","key":"10.1016\/j.phymed.2025.157500_bib0025","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC guidelines for the management of chronic coronary syndromes","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.phymed.2025.157500_bib0026","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12872-019-01289-z","article-title":"Tanshinone IIa prevents platelet activation and down-regulates CD36 and MKK4\/JNK2 signaling pathway","volume":"20","author":"Wang","year":"2020","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.phymed.2025.157500_bib0027","doi-asserted-by":"crossref","first-page":"652","DOI":"10.3389\/fphar.2020.00652","article-title":"Network pharmacology-based approach uncovers the mechanism of guanxinning tablet for treating thrombus by MAPKs signal pathway","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2025.157500_bib0028","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.2147\/DDDT.S479881","article-title":"Guanxinning tablet alleviates post-ischemic stroke injury via regulating complement and coagulation cascades pathway and inflammatory network mobilization","volume":"18","author":"Wang","year":"2024","journal-title":"Drug. Des. Devel. Ther."},{"key":"10.1016\/j.phymed.2025.157500_bib0029","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7128230","article-title":"Guanxinning tablet attenuates coronary atherosclerosis via regulating the gut microbiota and their metabolites in tibetan minipigs induced by a high-fat diet","volume":"2022","author":"Yang","year":"2022","journal-title":"J. Immunol. Res."},{"issue":"8","key":"10.1016\/j.phymed.2025.157500_bib0030","first-page":"589","article-title":"Guanxinning tablet inhibits the interaction between leukocyte integrin Mac-1 and platelet GPIb\u03b1 for antithrombosis without increased bleeding risk","volume":"20","author":"Yang","year":"2022","journal-title":"Chin J. Nat. Med."},{"issue":"16","key":"10.1016\/j.phymed.2025.157500_bib0031","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1001\/jama.2023.19524","article-title":"Traditional chinese medicine compound (Tongxinluo) and clinical outcomes of patients with acute myocardial infarction: the CTS-AMI randomized clinical trial","volume":"330","author":"Yang","year":"2023","journal-title":"JAMA"},{"issue":"16","key":"10.1016\/j.phymed.2025.157500_bib0032","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.2016.3775","article-title":"Development, validation of a prediction rule for benefit and harm of dual antiplatelet therapy beyond 1 year after percutaneous coronary intervention","volume":"315","author":"Yeh","year":"2016","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.phymed.2025.157500_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2024.102739","article-title":"A closer look into gastrointestinal bleeding in heart failure patients","volume":"49","author":"Zaher","year":"2024","journal-title":"Curr. Probl. Cardiol."},{"key":"10.1016\/j.phymed.2025.157500_bib0034","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6658704","article-title":"Clinical study for safety evaluation of GXN tablets combined with aspirin in long-term treatment of coronary heart disease","volume":"2021","author":"Zi","year":"2021","journal-title":"Evid. Based. Complement Alternat. Med"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325011377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325011377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T11:23:12Z","timestamp":1766661792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711325011377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":34,"alternative-id":["S0944711325011377"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2025.157500","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guanxinning tablets plus aspirin versus aspirin monotherapy to reduce cardiovascular events after percutaneous coronary intervention: A cluster-randomized controlled trial (GAP trial)","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2025.157500","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"157500"}}